First Manhattan’s CalciMedica CALC Stock Holding History

First Manhattan’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.14K	Hold	13,226	–	–	﹤0.01%	753
2025 Q4	$87.2K	Hold	13,226	–	–	﹤0.01%	717
2025 Q3	$40.7K	Hold	13,226	–	–	﹤0.01%	711
2025 Q2	$21.2K	Hold	13,226	–	–	﹤0.01%	695
2025 Q1	$25.3K	Buy	+13,226	New	+$33K	﹤0.01%	673
2024 Q4	–	Sell	-13,226	Closed	-$58.6K	–	685
2024 Q3	$58.6K	Hold	13,226	–	–	﹤0.01%	673
2024 Q2	$52.4K	Hold	13,226	–	–	﹤0.01%	657
2024 Q1	$55K	Hold	13,226	–	–	﹤0.01%	866
2023 Q4	$37.8K	Hold	13,226	–	–	﹤0.01%	921
2023 Q3	$35.2K	Hold	13,226	–	–	﹤0.01%	941
2023 Q2	$53K	Buy	+13,226	New	+$57.8K	﹤0.01%	880
2023 Q1	–	Sell	-19,381	Closed	-$136K	–	1550
2022 Q4	$136K	Sell	19,381 -1,476	-7%	-$16.6K	﹤0.01%	775
2022 Q3	$274K	Hold	20,857	–	–	﹤0.01%	630
2022 Q2	$318K	Hold	20,857	–	–	﹤0.01%	619
2022 Q1	$359K	Hold	20,857	–	–	﹤0.01%	645
2021 Q4	$534K	Hold	20,857	–	–	﹤0.01%	556
2021 Q3	$969K	Hold	20,857	–	–	﹤0.01%	431
2021 Q2	$1.58M	Buy	+20,857	New	+$1.37M	0.01%	366

Other funds holding CALC

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

SFFS

Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

First Manhattan's CALC Position: Q1 2026 in Review

First Manhattan held its CalciMedica (CALC) position steady in Q1 2026 at 13,226 shares worth $7.14K. The position accounts for ﹤0.01% of the portfolio, ranked #753.

First Manhattan first reported a position in CALC in Q2 2021 and has held it in 18 quarters since. The position peaked at $1.58M in Q2 2021. 27 funds tracked by Wall St. Rank hold CALC as of Q1 2026.

First Manhattan held 13,226 shares of CalciMedica worth $7.14K as of Q1 2026.
First Manhattan left its CalciMedica share count unchanged in Q1 2026.
CalciMedica made up ﹤0.01% of First Manhattan's portfolio in Q1 2026, its #753 holding.
First Manhattan first reported a position in CalciMedica in Q2 2021 and has held it in 18 quarters since.
First Manhattan's CalciMedica position peaked at $1.58M in Q2 2021.
27 funds tracked by Wall St. Rank held CalciMedica as of Q1 2026.

Based on First Manhattan's 13F filing for Q1 2026, filed 15 May 2026.